Cited by

• Pathogenesis of malaria revisited.

  Dasari P, Bhakdi S. Dasari P, et al. Med Microbiol Immunol. 2012 Nov;201(4):599-604. doi: 10.1007/s00430-012-0265-y. Epub 2012 Sep 7. Med Microbiol Immunol. 2012. PMID: 22955244 Review.
• Plasmodium falciparum schizont sonic extracts suppress lymphoproliferative responses to mitogens and antigens in malaria-immune adults.

  Riley EM, Jobe O, Blackman M, Whittle HC, Greenwood BM. Riley EM, et al. Infect Immun. 1989 Oct;57(10):3181-8. doi: 10.1128/iai.57.10.3181-3188.1989. Infect Immun. 1989. PMID: 2528508 Free PMC article.
• WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study.

  Nadjm B, Amos B, Mtove G, Ostermann J, Chonya S, Wangai H, Kimera J, Msuya W, Mtei F, Dekker D, Malahiyo R, Olomi R, Crump JA, Whitty CJ, Reyburn H. Nadjm B, et al. BMJ. 2010 Mar 30;340:c1350. doi: 10.1136/bmj.c1350. BMJ. 2010. PMID: 20354024 Free PMC article.
• Kinetic and Cross-Sectional Studies on the Genesis of Hypoargininemia in Severe Pediatric Plasmodium falciparum Malaria.

  Rubach MP, Zhang H, Florence SM, Mukemba JP, Kalingonji AR, Anstey NM, Yeo TW, Lopansri BK, Thompson JW, Mwaikambo ED, Young S, Millington DS, Weinberg JB, Granger DL. Rubach MP, et al. Infect Immun. 2019 Mar 25;87(4):e00655-18. doi: 10.1128/IAI.00655-18. Print 2019 Apr. Infect Immun. 2019. PMID: 30718287 Free PMC article.
• Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study.

  Scott JA, Berkley JA, Mwangi I, Ochola L, Uyoga S, Macharia A, Ndila C, Lowe BS, Mwarumba S, Bauni E, Marsh K, Williams TN. Scott JA, et al. Lancet. 2011 Oct 8;378(9799):1316-23. doi: 10.1016/S0140-6736(11)60888-X. Epub 2011 Sep 6. Lancet. 2011. PMID: 21903251 Free PMC article.